Tc99m-labeled murine antibody fragment for nuclear imaging of activated granulocytes. Primary potential use is to differentiate soft-tissue infection from osteomyelitis and diagnose equivocal appendicitis. It is currently marketed in European Union for diagnosing osteomyelitis, BLA under review by US FDA.